Measuring microdose ABY-029 fluorescence signal in a primary human soft-tissue sarcoma resection
Near-infrared (NIR) fluorescence combined with targeting epidermal growth factor receptor
(EGFR) overexpression for surgical guidance in many cancers is gaining momentum. ABY …
(EGFR) overexpression for surgical guidance in many cancers is gaining momentum. ABY …
Measuring microdose ABY-029 fluorescence signal in a primary human soft-tissue sarcoma resection
K Samkoe, HS Sardar, J Gunn, J Feldwisch… - Proc. of SPIE … - spiedigitallibrary.org
Microdose administration of ABY-029, an anti-epidermal growth factor receptor Affibody
molecule conjugated to IRDye 800CW, is being studied in a Phase 0 trial for resection of soft …
molecule conjugated to IRDye 800CW, is being studied in a Phase 0 trial for resection of soft …
[HTML][HTML] Measuring microdose ABY-029 fluorescence signal in a primary human soft-tissue sarcoma resection
KS Samkoe, HS Sardar, J Gunn… - Proceedings of SPIE …, 2019 - ncbi.nlm.nih.gov
Microdose administration of ABY-029, an anti-epidermal growth factor receptor Affibody
molecule conjugated to IRDye 800CW, is being studied in a Phase 0 trial for resection of soft …
molecule conjugated to IRDye 800CW, is being studied in a Phase 0 trial for resection of soft …
Measuring microdose ABY-029 fluorescence signal in a primary human soft-tissue sarcoma resection
KS Samkoe, H Shahzad Sardar… - … , and Applications V, 2019 - ui.adsabs.harvard.edu
Near-infrared (NIR) fluorescence combined with targeting epidermal growth factor receptor
(EGFR) overexpression for surgical guidance in many cancers is gaining momentum. ABY …
(EGFR) overexpression for surgical guidance in many cancers is gaining momentum. ABY …
Measuring microdose ABY-029 fluorescence signal in a primary human soft-tissue sarcoma resection.
KS Samkoe, HS Sardar, J Gunn… - Proceedings of Spie …, 2019 - europepmc.org
Microdose administration of ABY-029, an anti-epidermal growth factor receptor Affibody
molecule conjugated to IRDye 800CW, is being studied in a Phase 0 trial for resection of soft …
molecule conjugated to IRDye 800CW, is being studied in a Phase 0 trial for resection of soft …
Measuring microdose ABY-029 fluorescence signal in a primary human soft-tissue sarcoma resection
KS Samkoe, HS Sardar, J Gunn… - … of SPIE--the …, 2019 - pubmed.ncbi.nlm.nih.gov
Microdose administration of ABY-029, an anti-epidermal growth factor receptor Affibody
molecule conjugated to IRDye 800CW, is being studied in a Phase 0 trial for resection of soft …
molecule conjugated to IRDye 800CW, is being studied in a Phase 0 trial for resection of soft …
Measuring microdose ABY-029 fluorescence signal in a primary human soft-tissue sarcoma resection.
KS Samkoe, HS Sardar, J Gunn… - Proceedings of Spie …, 2019 - europepmc.org
Microdose administration of ABY-029, an anti-epidermal growth factor receptor Affibody
molecule conjugated to IRDye 800CW, is being studied in a Phase 0 trial for resection of soft …
molecule conjugated to IRDye 800CW, is being studied in a Phase 0 trial for resection of soft …